A Complete Guide to the Trading of Rights Entitlements (REs): Genesys International Corporation Limited

As Genesys International Corporation Limited rolls out its highly anticipated rights issue, eligible shareholders and market participants are gearing up for the trading of Rights Entitlements (REs).

A Complete Guide to the Trading of Rights Entitlements (REs): Genesys International Corporation Limited

As Genesys International Corporation Limited rolls out its highly anticipated rights issue, eligible shareholders and market participants are gearing up for the trading of Rights Entitlements (REs). Opening for subscription on August 14, 2026, the ₹125.37-crore rights issue presents a strategic opportunity for investors to either expand their holdings at a discounted price or monetize their entitlements through the open market.

Here is an in-depth look at the trading of Rights Entitlements and what you need to know about the Genesys International rights issue.

Understanding the Rights Issue and REs Genesys International Corporation has approved a rights issue of up to 2.51 crore equity shares. Existing shareholders who held shares of the company as of the record date (August 6, 2026) are eligible to receive Rights Entitlements.

The company has set the entitlement ratio at 3:5, meaning shareholders receive 3 Rights Entitlements for every 5 fully paid-up equity shares held. These REs were credited to the demat accounts of eligible investors on August 7, 2026.

However, receiving REs does not mean you automatically receive the rights shares. REs merely represent the right to apply for the actual shares at the prescribed issue price of ₹50 per share.

Trading of Rights Entitlements (GENESYS-RE) For those who do not wish to subscribe to the rights issue, the stock exchanges offer a window to sell these entitlements. The REs will be temporarily traded on the stock exchanges under a separate ticker.

RE Trading Symbol: GENESYS-RE
RE Trading Window: August 14, 2026, to August 18, 2026

During this window, shareholders can sell their REs in the open market just like regular shares. Conversely, investors who did not hold Genesys shares on the record date but wish to participate in the rights issue can purchase these REs from the open market and subsequently apply for the rights shares.

Important Note: The trading window for REs closes a few days before the actual rights issue closes. Once the trading window shuts on August 18, you can no longer buy or sell REs on the exchange.

Key Dates for the Rights Issue If you are planning to trade REs or apply for the rights shares, keep the following timeline in mind: *Issue Opens:** August 14, 2026 *RE Trading Closes:** August 18, 2026 *Issue Closes:** August 21, 2026 *Tentative Date of Allotment:** August 24, 2026 *Listing of Rights Shares:** August 25, 2026

What Are Your Options as an RE Holder? If you have REs in your demat account, you generally have three choices:

Apply for the Rights Shares: You can use your REs to apply for the actual equity shares of Genesys International by paying the issue price of ₹50 per share. This can be done online via Netbanking ASBA or offline by submitting a physical form to a Self-Certified Syndicate Bank (SCSB).
Renounce (Sell) Your REs: If you do not want to invest more capital into the company, you can sell your REs on the stock exchange between August 14 and August 18. This allows you to realize a cash premium for your entitlements.
Do Nothing (Let them Lapse): This is highly discouraged. If you neither apply for the rights shares nor sell your REs by the respective deadlines, your REs will be extinguished and lapse worthless. You will lose both the opportunity to buy shares at a discount and the premium you could have gained by selling them.

Objective of the Issue The funds raised through this ₹125.37-crore rights issue will primarily be used to fuel the company's growth and manage its finances. Genesys International plans to utilize roughly ₹88 crore to fund working capital requirements. Another ₹14.89 crore will be directed toward the adjustment of unsecured promoter loans, while the remainder will be deployed for general corporate purposes and issue expenses.

As the RE trading kicks off, investors should carefully weigh their investment strategies to make the most of this corporate action.